A bioactive constituent of Phochinenin I (PI), a dihydrophenanthrene-type monomer, has been isolated from the pseudobulb for more than 15 years, but its activity has not been reported. This study discovered its protective effects on the inflammatory response and oxidative stress for the very first time. The LPS/IFN-γ-induced RAW264.7 model and H(2)O(2)-induced zebrafish model were used to evaluate the regulatory effects of PI on oxidative stress, and RNA sequencing analysis was performed to explore its possible molecular mechanism. First, PI alleviated the pro-inflammatory response by decreasing tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels and reduced nitric oxide (NO) secretion by inhibiting inducible nitric oxide synthase (iNOS) expression. Next, PI might reduce reactive oxygen species (ROS) production by enhancing nuclear factor erythroid 2-related factor 2 (Nrf2) expression. Western blotting results showed that PI alleviated the cellular inflammatory response mainly by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3) and downregulating c-Myc expression, accompanied by reducing autophagy markers LC3B and SQSTM1/p62 accumulation. c-Myc is a target connected with many anti-inflammatory and antioxidant pathways. RNA sequencing data highlighted phagosome pathway regulation and SQSTM1/p62-associated gene networks as key mediators of PI's immunomodulatory effects. In vivo, using H(2)O(2)-challenged zebrafish embryos, PI conferred significant protection against oxidative injury, manifested by ROS scavenging along with antioxidant enhancement, which included elevated superoxide dismutase (SOD) activity and upregulated expression of Mn-SOD, Cu/Zn-SOD, and NAD-(P)-H:quinone oxidoreductase 1 (NQO1) genes. PI can be used as a pharmaceutical chemistry derivative of anti-inflammatory lead compounds and as a new candidate for future adjuvant therapy.
Phochinenin I, a Bioactive Constituent from , Attenuates Inflammatory Response and Oxidative Stress In Vitro and In Vivo.
芍药苷元 I 是一种生物活性成分,可在体外和体内减轻炎症反应和氧化应激
阅读:7
作者:Li Ye, Ren Guanghui, Wang Wei, Li Hongyan, Li Ang, Wang Yongjie
| 期刊: | ACS Omega | 影响因子: | 4.300 |
| 时间: | 2025 | 起止号: | 2025 Jun 16; 10(25):26488-26499 |
| doi: | 10.1021/acsomega.4c11614 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
